Navigation Links
Valeant Pharmaceuticals Reports 2013 Third Quarter Financial Results
Date:10/31/2013

ended September 30, 2013 legal settlement and related fees of $149.6 million primarily relating to a settlement agreement with Anacor Pharmaceuticals, Inc.(h) Restructuring, acquisition-related and other costs of $304.5 million primarily represent costs relating to the acquisitions of Bausch & Lomb Holdings Incorporation, Medicis Pharmaceutical Corporation, Obagi Medical Products, Inc. and other Valeant restructuring and integration initiatives.
These include $165.2 million relating to employee severance costs, $54.1 million of stock-based compensation, $66.1 million relating to duplicative labor, contract terminations, integration consulting, transition services, and other, $8.7 million relating to acquisition costs, $5.5 million relating to facility closure costs, $2.5 million relating to other, $1.8 million relating to non-personnel manufacturing integration costs and $0.6 million of other non-cash charges.(i) Restructuring, acquisition-related and other costs of $47.5 million represent costs relating to internal Valeant restructuring and integration initiatives and the acquisitions of Medicis Pharmaceutical Corporation, iNova, Dermik and Sanitas.  These include $18.5 million relating to integration consulting, duplicative labor, transition services, and other, $14.4 million relating to employee severance costs, $4.6 million relating to acquisition costs, $3.8 million relating to facility closure costs and $6.2 million relating to other.(j) Non-cash interest expense associated with amortization and write-down of deferred financing costs and debt discounts for the three months ended September 30, 2013 of $27.6 million.  For the three months ended September 30, 2012 non-cash interest expense associated with amortization and write-down of deferred financing costs, debt discounts and ASC 470-20 (FSP APB 14-1) interest, $8.9 million.(k) Unrealized foreign exchange on intercompany financing arrangements, $7.7 million.(l) Total tax effect of non-GAAP p
'/>"/>
SOURCE Valeant Pharmaceuticals International, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21

Related medicine technology :

1. Valeant Pharmaceuticals Agrees To Acquire AcneFree And Certain Assets From University Medical
2. Valeant Pharmaceuticals Reports 2012 First Quarter Financial Results
3. Valeant Pharmaceuticals To Host Investor Day
4. Valeant Pharmaceuticals To Announce 2012 Second Quarter Results On August 2, 2012
5. Valeant Pharmaceuticals International, Inc. Agrees To Acquire Medicis Pharmaceutical Corporation For $44.00 Per Share In Cash
6. Valeant Pharmaceuticals To Present At UBS Annual Global Life Sciences Conference
7. Valeant Pharmaceuticals Announces Management Change
8. Valeant Pharmaceuticals To Syndicate Incremental Loans
9. Valeant Pharmaceuticals Appoints Howard Schiller To Board Of Directors
10. Valeant Pharmaceuticals Announces Launch of Concurrent Private Offerings of Senior Notes
11. Valeant Pharmaceuticals International, Inc. Announces Pricing Of Concurrent Private Offerings Of Senior Notes
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/27/2015)... August 27, 2015 According to a new ... Toilet, Seating, Universal, Standing, Bariatric ), Material (Nylon, Padded, Canvas), Usage ... 2020", published by MarketsandMarkets, the Medical Lifting Sling Market is poised ... in 2015, at a CAGR of 11.4 % from 2015 to ... ma rket data T ables and 65 ...
(Date:8/27/2015)... 2015  Now that Intuitive Surgical, Inc.® has announced ... robot, hospitals with robotic surgery programs need to think ... see where they stand with robotic surgery. Are they ... they adopted best practices for safety? Should they plan ... ECRI Institute, which has nearly 50 years, ...
(Date:8/27/2015)... BIRMINGHAM, Ala. , Aug. 27, 2015 ... Integrated Outpatient Pharmacy Provider (IOPP™) is expanding ... launch of a medication-focused transition of care ... program, named "RxCare Management," provides hospitals with ... improve hospital performance measures that have been ...
Breaking Medicine Technology:Medical Lifting Sling Market Worth USD 706.0 Million by 2020 2Medical Lifting Sling Market Worth USD 706.0 Million by 2020 3Medical Lifting Sling Market Worth USD 706.0 Million by 2020 4ECRI Institute's New Robotic Surgery Service Helps Hospitals Brace for Change 2ECRI Institute's New Robotic Surgery Service Helps Hospitals Brace for Change 3Rx Care Management by Proxsys Rx - Transition of Care Technology Helps Prevent Hospital Medication Errors 2
... 18, 2012 Generex Biotechnology Corporation (OTCBB: GNBT) ... Scientific Advisory Board (SAB) of its wholly-owned subsidiary, ... cancer vaccine.  The following distinguished scientists, scholars, and ... (University of Texas MD Anderson Cancer Center), Dr. ...
... NATICK, Mass., May 17, 2012  Boston Scientific Corporation (NYSE: ... Administration approval and market launch of the Epic™ Vascular ... open blocked arteries in patients with iliac artery stenosis, ... leg pain caused by insufficient blood flow.  ...
Cached Medicine Technology:Generex Augments Antigen Express Scientific Advisory Board 2Generex Augments Antigen Express Scientific Advisory Board 3Generex Augments Antigen Express Scientific Advisory Board 4Boston Scientific Announces FDA Approval and U.S. Launch of EPIC™ Vascular Stent 2Boston Scientific Announces FDA Approval and U.S. Launch of EPIC™ Vascular Stent 3Boston Scientific Announces FDA Approval and U.S. Launch of EPIC™ Vascular Stent 4Boston Scientific Announces FDA Approval and U.S. Launch of EPIC™ Vascular Stent 5
(Date:8/29/2015)... ... August 29, 2015 , ... Vascular Health ... and sell Arterosil and Arterosil HP, and that all claims and counterclaims have ... Health Sciences, LLC (VHS) in the United States District Court for the Southern ...
(Date:8/28/2015)... , ... August 28, 2015 , ... The Kentucky State ... are qualified for the position they are applying for, they are unable to pass ... employers are considering altering drug testing policies in order to be able to hire ...
(Date:8/28/2015)... ... ... As reported by Medical Daily on August 22 , Cellfina, a ... for two years, the longest of any cellulite reduction system currently on the market. ... effective solution for their cellulite, according to Dr. Robert Weiss, director of the premier ...
(Date:8/28/2015)... ... August 28, 2015 , ... “ Frequentz ” was featured on NewsWatch ... coolest applications on the market for iOS, Android, and Windows. Joe Toohey, the host ... this software allows businesses to track product movement from beginning to end. , Businesses ...
(Date:8/28/2015)... Utah (PRWEB) , ... August 28, 2015 , ... ... awarded a three-year accreditation for its adolescent residential, counseling, day treatment and intensive ... that it meets international standards for quality and its pursuit of excellence. As ...
Breaking Medicine News(10 mins):Health News:Hiring Obstacles: Drug Abuse a Problem for Workforce 2Health News:Hiring Obstacles: Drug Abuse a Problem for Workforce 3Health News:Hiring Obstacles: Drug Abuse a Problem for Workforce 4Health News:Maryland Dermatologists Discuss Non-Invasive Cellulite Reduction System Cellfina Receiving 2-Year FDA Clearance 2Health News:Maryland Dermatologists Discuss Non-Invasive Cellulite Reduction System Cellfina Receiving 2-Year FDA Clearance 3Health News:Track Product Movement from Beginning to End with Frequentz 2Health News:West Ridge Academy Awarded CARF Three-Year Accrediation 2
... ... scientists and engineers, metallurgists, product designers, researchers, and clinicians is coming to Minneapolis, Aug. ... (Vocus) ... and engineers, metallurgists, product designers, researchers, and clinicians is coming to Minneapolis, Aug. 10-12., ...
... as one of the Nation,s Leading "Social Innovators" for Healthcare ... House , , CONCORD, Mass., July 1 Dr. ... of Children,s Books, has been selected by the Obama Administration ... In an exclusive reception at the White House this ...
... BELGRADE, SERBIA, July 1 /PRNewswire-FirstCall/ - Hard To Treat ... Slavica BioChem subsidiary, Dr. Sanja Pekovic provided updates on ... the use of Ribavirin And Tiazofurin for the potential ... "It is now well accepted that axonal injury begins ...
... may hold key to understanding how to repair the organ ... time, researchers have identified a single "master" stem cell in ... cell types that make up the human heart. , "This ... and that is understanding how the human heart is built, ...
... by Peter V. Lee and Debra L. Ness, co-chairs of ... In a major step forward for our nation,s health, ... 100 illnesses in its new report, "The Initial National Priorities ... the heels of a $1.1 billion appropriation by Congress in ...
... protein and cholesterol are associated with a higher risk of ... diets high in carbohydrates are associated with a lower risk. ... , a journal published by John Wiley & Sons on ... Diseases (AASLD). The article is also available online at Wiley ...
Cached Medicine News:Health News:Materials and Processes for Medical Devices Event Brings Clinicians, Engineers, Designers Together 2Health News:Materials and Processes for Medical Devices Event Brings Clinicians, Engineers, Designers Together 3Health News:Materials and Processes for Medical Devices Event Brings Clinicians, Engineers, Designers Together 4Health News:Charlotte Cowan MD Honored by Obama Administration for Innovative 'Doctor Hippo' Series of Children's Books 2Health News:Charlotte Cowan MD Honored by Obama Administration for Innovative 'Doctor Hippo' Series of Children's Books 3Health News:Charlotte Cowan MD Honored by Obama Administration for Innovative 'Doctor Hippo' Series of Children's Books 4Health News:Hard To Treat Diseases (HTDS) Clinical Trial Update on Therapeutic effects of Combined Treatment With Ribavirin And Tiazofurin 2Health News:Master Stem Cell for Human Heart Identified 2Health News:Master Stem Cell for Human Heart Identified 3Health News:Nation Takes a Big Step Toward Learning Which Medical Treatments Work Best, a Major Advance in Fixing Our Broken Health-Care System 2Health News:Study examines dietary influences of liver disease 2
... Orthofix Pelvic Fixator is achieved by means ... and a fixator assembly which consists of ... unit. A supplementary link may be used ... applications. With this new design, the ball-joint ...
For radial/ulnar translation, angulation, dorsal/volar translation, and incremental longitudinal distraction, this advanced system is appropriate when incremental adjustment provides an adjunctive me...
Provides basic reduction capabilities for angulation, rotation and length. Ball joint design offers fracture reduction in all planes....
... Clamps have a slender design contributes to ... of Kirschner wires. The Connecting Clamp allows ... and/or Connecting Bar. Uses 3.0 mm Carbon ... wires eliminate need to predrill and provide ...
Medicine Products: